ArticleOphthalmology and therapy2026
Selective Photocoagulation of Large Retinal Capillary Aneurysm (LRCA) by Navigated Focal Laser.
Article in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study aimed to evaluate the anatomical and functional outcome of selective photocoagulation of large retinal capillary aneurysm (LRCA) including telangiectatic capillaries (TelCaps) and perifoveal vascular anomalous complex (PVAC) by navigated focal laser (Navilas®, OD-OS GmBH, Teltwo, Germany).
methodsConsecutive patients with telangiectatic lesions greater than 150 µm in diameter were included in this analysis. All patients were treated with navigated focal laser, planned on multimodal imaging.
resultsFifty-one eyes of 50 patients were retrospectively analyzed. Navigated laser photocoagulation of LRCA successfully occluded 100% of the lesions, inducing significant improvement in best-corrected visual acuity (BCVA) at 3 (p = 0.002) and 6 months (p = 0.001). There was a significant decrease in central macular thickness (CMT) from 369 ± 97 µm at baseline to 298 ± 77.5 µm at 3 months (p = 0.0004) and to 281±87 µm at 6 months (p = 0.0004). No scar was detected in the macular region after the laser treatment.
conclusionLRCA arising from retinal capillaries are an ideal candidate for navigated laser treatment. Navigated focal treatment was shown to be effective and safe in occluding these kinds of lesions, with resolution of secondary edema and no side effects.
trial registrationNot applicable. This was a retrospective observational study and was not registered as a clinical trial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.